SCHEMBL20923972

SCHEMBL20923972

Oc1cccc(-c2ccc(C3CC3)nc2)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 9/20 0.63
HSD17B2 P37059 9/20 0.63
FYN P06241 1/20 0.57
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
PIK3CD O00329 1/20 0.47
PIK3CA P42336 1/20 0.47
NOTUM Q6P988 2/20 0.44
KDM1A O60341 3/20 0.43
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
METAP2 P50579 1/20 0.41
DYRK1A Q13627 1/20 0.41
DYRK1B Q9Y463 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20924072 0.81 NOTUM (0.50) FYNNOTUMKDM1AESR1ESR2
SCHEMBL23601916 0.81 NOTUM (0.44) NOTUMKDM1AMETAP2
SCHEMBL530999 0.80 KDM1A (0.61) HSD17B1HSD17B2FYNCYP3A4CYP2C9
SCHEMBL526881 0.80 KDM1A (0.61) HSD17B1HSD17B2FYNCYP3A4CYP2C9
SCHEMBL6837456 0.80 KDM1A (0.61) HSD17B1HSD17B2FYNCYP3A4CYP2C9
SCHEMBL527285 0.80 KDM1A (0.61) HSD17B1HSD17B2FYNCYP3A4CYP2C9
SCHEMBL526880 0.80 KDM1A (0.61) HSD17B1HSD17B2FYNCYP3A4CYP2C9
Hydrochloric Acid SCHEMBL15137040 0.79 KDM1A (0.60) HSD17B1HSD17B2FYNCYP3A4CYP2C9
Hydrochloric Acid SCHEMBL15137039 0.79 KDM1A (0.60) HSD17B1HSD17B2FYNCYP3A4CYP2C9
SCHEMBL944471 0.78 KDM1A (0.51) FYNKDM1AHDAC6DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598480-B1 CYCLOPROPYLAMINE DERIVATIVES USEFUL AS LSD1 INHIBITORS ORYZON GENOMICS SA (ES) 2019-04-24 EP disclosed